» Articles » PMID: 33672706

Inorganic Nanoparticle-Loaded Exosomes for Biomedical Applications

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Mar 6
PMID 33672706
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are intrinsic cell-derived membrane vesicles in the size range of 40-100 nm, serving as great biomimetic nanocarriers for biomedical applications. These nanocarriers are known to bypass biological barriers, such as the blood-brain barrier, with great potential in treating brain diseases. Exosomes are also shown to be closely associated with cancer metastasis, making them great candidates for tumor targeting. However, the clinical translation of exosomes are facing certain critical challenges, such as reproducible production and tracking of their localization, distribution, and ultimate fate. Recently, inorganic nanoparticle-loaded exosomes have been shown great benefits in addressing these issues. In this review article, we will discuss the preparation methods of inorganic nanoparticle-loaded exosomes, and their applications in bioimaging and therapy. In addition, we will briefly discuss their potentials in exosome purification.

Citing Articles

Advanced Nanomedicine Delivery Systems for Cardiovascular Diseases: Viral and Non-Viral Strategies in Targeted Therapy.

Chen Q, Yu T, Gong J, Shan H Molecules. 2025; 30(4).

PMID: 40005272 PMC: 11858567. DOI: 10.3390/molecules30040962.


Advances in the use of nanotechnology for treating gout.

Wang Y, Wang Z, Jiang H, Ni L, Ju H, Wu Y Nanomedicine (Lond). 2025; 20(4):355-369.

PMID: 39873132 PMC: 11812334. DOI: 10.1080/17435889.2025.2457315.


Nanoparticle Tracking Analysis: An Effective Tool to Characterize Extracellular Vesicles.

Kowkabany G, Bao Y Molecules. 2024; 29(19).

PMID: 39407601 PMC: 11477862. DOI: 10.3390/molecules29194672.


Roadmap on magnetic nanoparticles in nanomedicine.

Wu K, Wang J, Natekar N, Ciannella S, Gonzalez-Fernandez C, Gomez-Pastora J Nanotechnology. 2024; 36(4).

PMID: 39395441 PMC: 11539342. DOI: 10.1088/1361-6528/ad8626.


Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures.

Gao C, Xiong R, Zhang Z, Peng H, Gu Y, Xu W Transl Neurodegener. 2024; 13(1):43.

PMID: 39192378 PMC: 11348682. DOI: 10.1186/s40035-024-00436-7.


References
1.
Di H, Zeng E, Zhang P, Liu X, Zhang C, Yang J . General Approach to Engineering Extracellular Vesicles for Biomedical Analysis. Anal Chem. 2019; 91(20):12752-12759. DOI: 10.1021/acs.analchem.9b02268. View

2.
Betzer O, Barnoy E, Sadan T, Elbaz I, Braverman C, Liu Z . Advances in imaging strategies for in vivo tracking of exosomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019; 12(2):e1594. DOI: 10.1002/wnan.1594. View

3.
Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

4.
Chen H, Luo C, Yang M, Li J, Ma P, Zhang X . Intracellular uptake of and sensing with SERS-active hybrid exosomes: insight into a role of metal nanoparticles. Nanomedicine (Lond). 2020; 15(9):913-926. DOI: 10.2217/nnm-2019-0419. View

5.
Bose R, Kumar S, Zeng Y, Afjei R, Robinson E, Lau K . Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents. ACS Nano. 2018; 12(11):10817-10832. PMC: 6684278. DOI: 10.1021/acsnano.8b02587. View